Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HPAPI
Sort By
Newest First
1 / 2
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04
Apr 25, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06
Sep 27, 2022
Complex Chemistry
Solving Complex Chemical Problems Across All Phases of NCE Programs
Luigi Trussardo
Olon
PAO-10-21-CL-11
Oct 21, 2021
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
Marko Salo; Arne Grumann
Fermion
PAO-09-21-CL-05
Sep 16, 2021
High Potency
Streamlining Highly Potent Drug Commercialization
Norbert Straub; Uwe Korn; Robert Klehr
Fareva
PAO-04-21-CL-04
Apr 19, 2021
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Daniela Kovats
Fareva
PAO-01-21-CL-01
Jan 11, 2021
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Pierre Luzeau, Ph.D.
Seqens
PAP-Q4-20-CL-025
Dec 09, 2020
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
Deborah A. Graham
Avara Pharmaceutical Services
PAP-Q4-20-CL-003
Dec 09, 2020
SEQENS Inaugurates HPAPI Unit
Seqens
PR-M08-20-NI-47
Aug 28, 2020
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent
PR-M08-20-NI-13
Aug 07, 2020
HPAPIs
Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects
Brian P. Haney, Ph.D.
Curia (formerly AMRI)
PAP-Q2-20-CL-031
Jul 01, 2020
Investment
Should You Choose a Commercial HPAPI Manufacturer for Your Clinical Program?
David Bastie; George Hlass
Fareva
PAO-11-2019-CL-001
Dec 06, 2019
Global Network
Applying an Established and Continuously Upgraded Global Network for CDMO Services
Lorraine Hill
Aspen Pharma
PAP-Q3-19-CL-002-2034
Oct 28, 2019
HPAPI
Successful US FDA Inspection of Asymchem Tianjin 1 HPAPI Development and Manufacturing Facility
Asymchem
PR-M03-19-NI-077
Mar 27, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028
Mar 12, 2019
Lyophilization
Flow Sciences, Inc. Partners with Three Companies to Contain Lyophilization Process of New HPAPI
Flow Sciences, Inc.
PR-M01-19-NI-052
Jan 15, 2019
Oral Solid Dose
HPAPIs and Two-Piece Liquid-Fill Capsules: The Perfect Match
Tom Breshamer
CapsCanada
PAO-06-18-CL-001
Jun 14, 2018
The Introduction of Robotics: Creating a Truly Sterile Environment
Nice Insight
PTV-M03-17-IN-001
May 02, 2017
Joint Venture
Joint Venture Contract Services – A CDMO’s Approach to Being a True Partner
BIOVECTRA
PAP-Q03-16-CL-016
Aug 01, 2016
CRDMO
Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics
Steven R. Hagen, Ph.D.; Dawn Von Rohr
Curia (formerly AMRI)
PAP-Q03-16-CL-001
Aug 01, 2016
1 / 2
